Reset osmostat

Jump to navigation Jump to search

WikiDoc Resources for Reset osmostat

Articles

Most recent articles on Reset osmostat

Most cited articles on Reset osmostat

Review articles on Reset osmostat

Articles on Reset osmostat in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Reset osmostat

Images of Reset osmostat

Photos of Reset osmostat

Podcasts & MP3s on Reset osmostat

Videos on Reset osmostat

Evidence Based Medicine

Cochrane Collaboration on Reset osmostat

Bandolier on Reset osmostat

TRIP on Reset osmostat

Clinical Trials

Ongoing Trials on Reset osmostat at Clinical Trials.gov

Trial results on Reset osmostat

Clinical Trials on Reset osmostat at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Reset osmostat

NICE Guidance on Reset osmostat

NHS PRODIGY Guidance

FDA on Reset osmostat

CDC on Reset osmostat

Books

Books on Reset osmostat

News

Reset osmostat in the news

Be alerted to news on Reset osmostat

News trends on Reset osmostat

Commentary

Blogs on Reset osmostat

Definitions

Definitions of Reset osmostat

Patient Resources / Community

Patient resources on Reset osmostat

Discussion groups on Reset osmostat

Patient Handouts on Reset osmostat

Directions to Hospitals Treating Reset osmostat

Risk calculators and risk factors for Reset osmostat

Healthcare Provider Resources

Symptoms of Reset osmostat

Causes & Risk Factors for Reset osmostat

Diagnostic studies for Reset osmostat

Treatment of Reset osmostat

Continuing Medical Education (CME)

CME Programs on Reset osmostat

International

Reset osmostat en Espanol

Reset osmostat en Francais

Business

Reset osmostat in the Marketplace

Patents on Reset osmostat

Experimental / Informatics

List of terms related to Reset osmostat

In water-electrolyte imbalance, Reset osmostat is a cause of hyponatremia.

"The normal osmostat for vasopressin release is fixed between 275 and 295 mOsm/kg. When the serum osmolality is below 280 mOsm/kg in normal individuals, vasopressin levels are very low"[1].

Rest osmostat have been reported in a healthy patient[2].

Pathology

Reset osmostat may be a form of the syndrome of inappropriate antidiuretic hormone (SIADH)[3] and has been proposed to possibly be either[4]:

  • A type B SIADH. Type B SIADH may include reset osmostat, "characterized by a decline in plasma copeptin levels with increasing saline-stimulated serum osmolality...baseline hypovolemia could not be identified [in these patient]"[4]
  • A type C SIADH. Reset osmostat may be a Type C rather than Type b, "reset osmostat may in part be considered as a less severe variant of the type C defect..., where responsivity to osmotic challenges is completely lost. Copeptin release in this subtype was stable at levels within the normal physiologic range but was not suppressed by hypotonicity or stimulated in response to osmotic stimulation; thus, it deviates from the previously described type C"[4]

Alternatively, reset osmostat may not be a type of SIADH[5]. Maesaka has proposed this due to the reliable normal fractional urate excretion (FEurate) values in reset osmostat[6].

Psychogenic polydipsia may be related to reset osmostat[7] and has similar (normal) findings with the FEurate[8].

Diagnosis

The fractional urate excretion (FEurate) in reset osmostat should be: 4%-11% (normal) and is superior to serum urate[6][8].

If the FEurate is high (higher than 11%), this suggests SIADH, thiazide-induced hyponatremia, or renal salt wasting[8].

Importance

Recognizing reset osmostat maybe important as baseline sodium < 140 mEq/L is a predictor of thiazide-induced hyponatremia during thiazide therapy[9].

See also

External links

References

  1. Kuthiah N, Er C (2018). "Reset Osmostat: A Challenging Case of Hyponatremia". Case Rep Med. 2018: 5670671. doi:10.1155/2018/5670671. PMC 6247647. PMID 30532786.
  2. Lipschutz JH, Arieff AI (1994). "Reset osmostat in a healthy patient". Ann Intern Med. 120 (7): 574–6. doi:10.7326/0003-4819-120-7-199404010-00007. PMID 8116995.
  3. DeFronzo RA, Goldberg M, Agus ZS (1976). "Normal diluting capacity in hyponatremic patients. Reset osmostat or a variant of the syndrome of inappropriate antidiuretic hormone secretion". Ann Intern Med. 84 (5): 538–42. doi:10.7326/0003-4819-84-5-538. PMID 1275354.
  4. 4.0 4.1 4.2 Fenske WK, Christ-Crain M, Hörning A, Simet J, Szinnai G, Fassnacht M; et al. (2014). "A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis". J Am Soc Nephrol. 25 (10): 2376–83. doi:10.1681/ASN.2013080895. PMC 4178436. PMID 24722436.
  5. Maesaka JK, Imbriano L, Mattana J, Gallagher D, Bade N, Sharif S (2014). "Differentiating SIADH from Cerebral/Renal Salt Wasting: Failure of the Volume Approach and Need for a New Approach to Hyponatremia". J Clin Med. 3 (4): 1373–85. doi:10.3390/jcm3041373. PMC 4470189. PMID 26237607.
  6. 6.0 6.1 Imbriano LJ, Ilamathi E, Ali NM, Miyawaki N, Maesaka JK (2012). "Normal fractional urate excretion identifies hyponatremic patients with reset osmostat". J Nephrol. 25 (5): 833–8. doi:10.5301/jn.5000074. PMID 22307440.
  7. Hariprasad MK, Eisinger RP, Nadler IM, Padmanabhan CS, Nidus BD (1980). "Hyponatremia in psychogenic polydipsia". Arch Intern Med. 140 (12): 1639–42. PMID 7458496.
  8. 8.0 8.1 8.2 Maesaka JK, Imbriano LJ, Miyawaki N (2018). "Determining Fractional Urate Excretion Rates in Hyponatremic Conditions and Improved Methods to Distinguish Cerebral/Renal Salt Wasting From the Syndrome of Inappropriate Secretion of Antidiuretic Hormone". Front Med (Lausanne). 5: 319. doi:10.3389/fmed.2018.00319. PMC 6284366. PMID 30560127.
  9. Makam AN, Boscardin WJ, Miao Y, Steinman MA (2014). "Risk of thiazide-induced metabolic adverse events in older adults". J Am Geriatr Soc. 62 (6): 1039–45. doi:10.1111/jgs.12839. PMC 4128471. PMID 24823661. Review in: Ann Intern Med. 2014 Oct 21;161(8):JC11